“…Noteworthy, multiple novel antiviral treatments, including Nsp9 specific Camel single-domain antibodies, and siRNA targeting Nsp9, as well as vaccine strategy of de-optimization of codon pair bias in Nsp9, significantly decreased PRRSV replication in vitro and in vivo Liu et al, 2015;Xie et al, 2014;Zheng et al, 2015;Zhu et al, 2018). Finally, Nsp9 was found to associate with at least 9 PRRSV encoded proteins, including Nsp1α,Nsp1β,Nsp3,Nsp7α,Nsp7β,Nsp8,Nsp11,Nsp12,and nucleocapsid (N) protein, validating the notion of this protein as a core component of the viral replication/transcription complex (RTC) Liu et al, 2016;Nan et al, 2018). Further exploring the interaction of Nsp9 with host cellular proteins and analyzing the biological significance are necessary for fully understanding the replication mechanisms and pathogenesis of PRRSV .…”